Common Causes of Unplanned Returns After Dermatologic Procedures
- Post-excision bleeding is a leading cause of unplanned ED visits and after-hours calls after Mohs surgery and standard excisions. Patients on anticoagulants or antiplatelet agents are at elevated risk. Discharge instructions should specify the expected amount of ooze versus the bleeding volume that warrants emergency evaluation, and provide clear pressure application instructions before directing patients to call or seek care.
- Wound infection following excision or Mohs repair typically presents 3 to 7 days post-procedure. Instructions that describe the signs of normal healing alongside the specific signs of infection (increasing redness extending beyond the wound edge, warmth, purulent drainage, fever) allow patients to differentiate expected from abnormal findings without calling for reassurance on each.
- Allergic contact dermatitis from wound care products is a preventable cause of unplanned visits. Bacitracin is a common sensitizer and a source of allergic reactions misidentified as wound infections. The American Academy of Dermatology guidelines recommend plain petrolatum as the first-line wound ointment for post-surgical sites. Discharge instructions should specify the product name and concentration to use, not a category such as 'antibiotic ointment.'
- Activity restriction misunderstanding drives a portion of post-procedure complications. Patients who do not receive clear restrictions on lifting, bending, and physical exertion after Mohs reconstruction on the face, scalp, or trunk may experience wound dehiscence or hematoma formation. Instructions must state specific weight limits, specific activities to avoid, and the duration of those restrictions, not general guidance such as 'take it easy.'
- Suture-related questions generate a high volume of after-hours calls in dermatology practices. Instructions should state the type of sutures placed (absorbable vs. non-absorbable), the expected timeline for absorption or the date of suture removal, and what patients should do if a suture is felt, visible, or appears to be causing irritation before the scheduled visit.
Discharge Instruction Content Specific to Dermatologic Procedures
- Mohs surgery discharge instructions must cover: wound care frequency and specific products, activity restrictions with a defined timeframe, sun exposure restrictions for the healing wound, follow-up schedule including pathology result communication, and the warning signs of bleeding, infection, and dehiscence. For flap or graft repairs, instructions should describe what the repaired site will look like in the first 48 to 72 hours so patients can distinguish expected appearance from complications.
- Biopsy discharge instructions should address wound care for the biopsy site, expected healing timeline, how and when the patient will receive pathology results, and what steps to take if they have not heard within the practice's stated timeframe. The MIPS Quality Measure 265 (Biopsy Follow-Up) requires documentation that a follow-up plan was communicated to the patient for tissue diagnoses associated with risk. Discharge records should reflect this communication.
- Laser procedure instructions vary by modality and must be tailored to the specific device, energy level, and treatment area. At a minimum, instructions for ablative procedures must specify the wound care regimen, sun protection requirements, expected duration of redness and swelling, and the threshold for contacting the practice. Non-ablative procedures with milder downtime still require documentation of post-treatment restrictions on heat exposure, exercise, and topical product use.
- Cryotherapy and in-office destructive procedure instructions should describe expected tissue response (blister formation, eschar, sloughing) as part of the normal healing course. Patients who receive this information before leaving are less likely to present urgently for a wound that is healing as expected. Instructions should state when to leave a blister intact, when and how to drain it if it becomes tense, and the timeline for eschar separation.
MIPS Quality Measures and Documentation for Dermatology Practices
- MIPS Quality Measure 265 (Biopsy Follow-Up) applies to dermatology practices and requires that all patients with tissue biopsy results receive a documented follow-up plan. The measure specifies that the plan must be communicated to the patient and documented in the medical record within a defined timeframe. The eligible denominator covers patients who had a biopsy with a tissue diagnosis. Practices should confirm current measure specifications on the CMS Quality Payment Program website, as specifications are updated annually.
- MIPS Quality Measure 137 (Melanoma: Continuity of Care, Recall System) requires that patients with a diagnosis of melanoma have a documented recall system in place for follow-up skin examination. This measure evaluates whether the practice has a process for scheduling and tracking periodic surveillance visits. Gaps in recall system documentation are a common contributor to lower MIPS Quality Category scores in dermatology groups.
- The MIPS Improvement Activity 'Use of decision support and standardized treatment protocols' (IA_PCMH_3) applies to practices that implement systematic protocols for post-procedure care, including discharge instruction standardization. Practices that document the use of standardized, procedure-specific discharge instructions as part of a quality improvement activity may be able to credit this toward Improvement Activities category credit in their MIPS submission.
- Documentation of patient education at the time of discharge supports MIPS quality reporting for measures tied to patient safety and clinical outcomes. Records should reflect the specific instructions provided, the format (written, verbal, electronic), the language used, any interpreter services provided, and that the patient or responsible party was given the opportunity to ask questions before leaving.
QAPI Tracking for Dermatology Practices and ASCs
- Dermatology practices performing procedures in an ASC or office-based surgical setting should track unplanned post-procedure events as a QAPI indicator. Relevant data points include unplanned ED visits within 30 days of a dermatologic procedure, unscheduled callbacks related to wound concerns, and patient complaints involving confusion about post-procedure care instructions. Tracking these against procedure type identifies the specific instruction gaps most likely to drive avoidable contacts.
- Post-operative wound infection rates should be tracked against a denominator of total procedures performed, stratified by procedure type. The CDC and NHSN define surveillance periods for surgical site infections; for dermatologic excisions, a 30-day surveillance window is appropriate. Practices should have a mechanism for receiving and recording infection reports from patients who present to other providers after their procedure.
- Medical record audits for discharge instruction completeness support both quality improvement and compliance in dermatology practices credentialed under Joint Commission ambulatory standards or CMS Conditions for Coverage. Audits should confirm that written instructions were provided, the patient or responsible party received and acknowledged them, the instructions were tailored to the specific procedure, and any special circumstances such as anticoagulant use or immunosuppression were addressed.
- After-hours call logs are an underutilized data source for identifying discharge instruction gaps in dermatology. Categorizing call content by topic (bleeding, wound appearance, suture questions, product use) and linking each category to the procedure type and instruction set provided reveals which procedures generate the highest volume of preventable calls and where instruction revisions are most likely to reduce avoidable patient contacts.